These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17952013)

  • 21. Nitric oxide mechanisms of nebivolol.
    Maffei A; Lembo G
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
    Brodde OE; Philipp T
    Dtsch Med Wochenschr; 2006 Nov; 131(45):2545-50. PubMed ID: 17091442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasodilatory mechanism of levobunolol on vascular smooth muscle cells.
    Dong Y; Ishikawa H; Wu Y; Yoshitomi T
    Exp Eye Res; 2007 Jun; 84(6):1039-46. PubMed ID: 17459374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ENOS is not activated by nebivolol in human failing myocardium.
    Brixius K; Song Q; Malick A; Boelck B; Addicks K; Bloch W; Mehlhorn U; Schwinger RH
    Life Sci; 2006 Aug; 79(13):1234-41. PubMed ID: 16716362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term treatment with a beta-blocker with vasodilative capacities improves intrarenal endothelial function in experimental renal failure.
    Gschwend S; Haug MB; Nierhaus M; Schulz A; Vetter R; Kossmehl P; Orzechowski HD; Scholze J; Rothermund L; Kreutz R
    Life Sci; 2009 Sep; 85(11-12):431-7. PubMed ID: 19635487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exacerbation by nicotine of the cyclosporine A-induced impairment of beta-adrenoceptor-mediated renal vasodilation in rats.
    El-Gowilly SM; Ghazal AR; Gohar EY; El-Mas MM
    Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1164-71. PubMed ID: 18565199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major differences in gene expression in human coronary smooth muscle cells after nebivolol or metoprolol treatment.
    Wolf SC; Sauter G; Jobst J; Kempf VA; Risler T; Brehm BR
    Int J Cardiol; 2008 Mar; 125(1):4-10. PubMed ID: 17467819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.
    Prisant LM
    J Clin Pharmacol; 2008 Feb; 48(2):225-39. PubMed ID: 18083889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasorelaxant effect of taurine is diminished by tetraethylammonium in rat isolated arteries.
    Niu LG; Zhang MS; Liu Y; Xue WX; Liu DB; Zhang J; Liang YQ
    Eur J Pharmacol; 2008 Feb; 580(1-2):169-74. PubMed ID: 17997400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production.
    Broeders MA; Doevendans PA; Bekkers BC; Bronsaer R; van Gorsel E; Heemskerk JW; Egbrink MG; van Breda E; Reneman RS; van Der Zee R
    Circulation; 2000 Aug; 102(6):677-84. PubMed ID: 10931809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of nebivolol on vascular endothelial and myocardial function in diabetes mellitus.
    Doggen K; Fransen P; Lemmens K; De Keulenaer GW
    J Cardiovasc Pharmacol; 2011 Jul; 58(1):56-64. PubMed ID: 21499118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Airway smooth muscle relaxation induced by 5-HT(2A) receptors: role of Na(+)/K(+)-ATPase pump and Ca(2+)-activated K(+) channels.
    Campos-Bedolla P; Vargas MH; Segura P; Carbajal V; Calixto E; Figueroa A; Flores-Soto E; Barajas-López C; Mendoza-Patiño N; Montaño LM
    Life Sci; 2008 Sep; 83(11-12):438-46. PubMed ID: 18708073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The anti-inflammatory effects of nebivolol in human coronary smooth muscle cells: clinical implications.
    Celik T; Iyisoy A; Kardesoglu E; Fici F
    Int J Cardiol; 2009 Apr; 133(3):415-6. PubMed ID: 18237789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
    Mahmud A; Feely J
    Am J Hypertens; 2008 Jun; 21(6):663-7. PubMed ID: 18437130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasorelaxant effect of isopropyl 3-(3, 4-dihydroxyphenyl)-2-hydroxypropanoate, a novel metabolite from Salvia miltiorrhiza, on isolated rat mesenteric artery.
    Wang SP; Zang WJ; Kong SS; Yu XJ; Sun L; Zhao XF; Wang SX; Zheng XH
    Eur J Pharmacol; 2008 Jan; 579(1-3):283-8. PubMed ID: 17976578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Load-induced cardiomyocyte apoptosis in cultured multicellular myocardial preparations is unaltered in presence of the beta-adrenoceptor antagonist nebivolol.
    Janssen PM; Zeitz O; Schumann H; Holtz J; Hasenfuss G
    Pharmacology; 2009; 83(3):141-7. PubMed ID: 19122477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nebivolol increases arterial distensibility in vivo.
    McEniery CM; Schmitt M; Qasem A; Webb DJ; Avolio AP; Wilkinson IB; Cockcroft JR
    Hypertension; 2004 Sep; 44(3):305-10. PubMed ID: 15262912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nebivolol has protective effect against endothelial and ileal dysfunction due to I/R.
    Soydan G; Cekiç EG; Tuncer M
    J Surg Res; 2011 Mar; 166(1):156-61. PubMed ID: 19922953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldosterone-induced coronary dysfunction in transgenic mice involves the calcium-activated potassium (BKCa) channels of vascular smooth muscle cells.
    Ambroisine ML; Favre J; Oliviero P; Rodriguez C; Gao J; Thuillez C; Samuel JL; Richard V; Delcayre C
    Circulation; 2007 Nov; 116(21):2435-43. PubMed ID: 17984374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quercetin antagonism of Bay K 8644 effects on rat tail artery L-type Ca(2+) channels.
    Saponara S; Sgaragli G; Fusi F
    Eur J Pharmacol; 2008 Nov; 598(1-3):75-80. PubMed ID: 18789318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.